OPKO Completes Acquisition Of PROLOR Biotech

By: Benzinga
OPKO Health, Inc. (NYSE: OPK ) and PROLOR Biotech, Inc. (NYSE: PBTH ) ("PROLOR") jointly announced today the completion of the acquisition of PROLOR by OPKO. Pursuant to the acquisition, stockholders of PROLOR will receive 0.9951 shares of OPKO common stock for each share of PROLOR common
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.